About 7.4 million obese Americans could have insurance coverage for drugs like Ozempic and Wegovy if the Trump administration ...

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...

A Texas federal judge has sided with UnitedHealthcare in determining regulators messed up calculating its Medicare Advantage ...

Insurers could save 20% in administrative costs and 10% in medical costs by harnessing the technology, experts said during a ...

The three companies are claiming the FTC’s suit is unconstitutional because it was lodged in the agency’s administrative ...

contextflow’s AI-driven technology enables radiologists to track lung nodules over time, assess malignancy, and generate high ...

Almost three-fourths of employers believe that increasing healthcare costs lead to trade-offs with salary or wage increases and could necessitate more cost-shifting to employees, according to ...

AI could ease labor shortages, but health systems will need to increase cybersecurity spending to manage heightened risks, ...

Mike Pykosz, who joined CVS with its acquisition of the value-based medical chain in 2023, is departing amid a flurry of high ...

In 2024, coverage for obesity drugs increased to 44% among employers with 500 or more workers, compared to 41% last year, the ...

“RFK Jr. has championed issues like healthy foods and the need for greater transparency in our public health infrastructure,” ...

Mass General Brigham, Emory and other providers will assess different AI models from companies like Google, Microsoft and ...